Rachid Izzar

CIK: 0001875506

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (6.7%)

Position reduction

Option Exercises (M)6 (40.0%)

Derivative conversions

Awards (A)2 (13.3%)

Compensation grants

Other (G, F, J, C, D, …)6 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIIB

BIOGEN INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

BIIB
BIOGEN INC.
Feb 13, 2026
Award(A)
Restricted Stock Unit
Direct
7.4K shares-
BIIB
BIOGEN INC.
Feb 6, 2026
Exercise(M)
Direct
2K shares-
BIIB
BIOGEN INC.
Feb 6, 2026
Tax Payment(F)
Direct
805 shares at avg. $201.18$162K
BIIB
BIOGEN INC.
Feb 6, 2026
Exercise(M)
Direct
1.8K shares-
BIIB
BIOGEN INC.
Feb 6, 2026
Tax Payment(F)
Direct
458 shares at avg. $201.18$92K
BIIB
BIOGEN INC.
Feb 6, 2026
Exercise(M)
Direct
3K shares-
BIIB
BIOGEN INC.
Feb 6, 2026
Tax Payment(F)
Direct
775 shares at avg. $201.18$156K
BIIB
BIOGEN INC.
Jul 8, 2025
Sale(S)
Direct
2.2K shares at avg. $135.00$300K
BIIB
BIOGEN INC.
Feb 10, 2025
Exercise(M)
Direct
1.5K shares-
BIIB
BIOGEN INC.
Feb 10, 2025
Tax Payment(F)
Direct
445 shares at avg. $142.54$63K
BIIB
BIOGEN INC.
Feb 7, 2025
Tax Payment(F)
Direct
565 shares at avg. $141.35$80K
BIIB
BIOGEN INC.
Feb 7, 2025
Exercise(M)
Direct
1.8K shares-
BIIB
BIOGEN INC.
Feb 7, 2025
Exercise(M)
Direct
2K shares-
BIIB
BIOGEN INC.
Feb 7, 2025
Tax Payment(F)
Direct
600 shares at avg. $141.35$85K
BIIB
BIOGEN INC.
Feb 6, 2025
Award(A)
Restricted Stock Unit
Direct
9.1K shares-

		Type	Shares	Price		Ownership
Feb 13, 2026	BIIB BIOGEN INC.	Award(A) Restricted Stock Unit	7,390	-	-	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Exercise(M)	2,044	-	$0	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Tax Payment(F)	805	$201.18	$161,950	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Exercise(M)	1,802	-	$0	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Tax Payment(F)	458	$201.18	$92,140	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Exercise(M)	3,043	-	$0	Direct
Feb 6, 2026	BIIB BIOGEN INC.	Tax Payment(F)	775	$201.18	$155,915	Direct
Jul 8, 2025	BIIB BIOGEN INC.	Sale(S)	2,223	$135.00	$300,105	Direct
Feb 10, 2025	BIIB BIOGEN INC.	Exercise(M)	1,515	-	-	Direct
Feb 10, 2025	BIIB BIOGEN INC.	Tax Payment(F)	445	$142.54	$63,430	Direct
Feb 7, 2025	BIIB BIOGEN INC.	Tax Payment(F)	565	$141.35	$79,863	Direct
Feb 7, 2025	BIIB BIOGEN INC.	Exercise(M)	1,801	-	-	Direct
Feb 7, 2025	BIIB BIOGEN INC.	Exercise(M)	2,043	-	-	Direct
Feb 7, 2025	BIIB BIOGEN INC.	Tax Payment(F)	600	$141.35	$84,810	Direct
Feb 6, 2025	BIIB BIOGEN INC.	Award(A) Restricted Stock Unit	9,130	-	-	Direct

1-15 of 15 transactions

About Izzar Rachid

Izzar Rachid (SEC CIK 0001875506) files insider reports with the SEC as Head of Global Product Strat. of BIOGEN INC. (BIIB).

Signal8 holds 6 ownership filings by Izzar Rachid, all Form 4s, filed between Feb 10, 2025 and Feb 17, 2026. Those filings report 15 transactions, from Feb 6, 2025 to Feb 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Izzar Rachid's filings is in CAMBRIDGE, MA.

Recent filings by Izzar Rachid

Feb 13, 2026: Grant or award of BIIB derivative securities (Form 4, code A).
Feb 6, 2026: Option exercise of BIIB shares (Form 4, code M).
Feb 6, 2026: Tax withholding of BIIB shares (Form 4, code F).
Feb 6, 2026: Option exercise of BIIB shares (Form 4, code M).
Feb 6, 2026: Tax withholding of BIIB shares (Form 4, code F).

Other insiders filing for BIOGEN INC. (BIIB)

Grogan Jane, Head of Research
Godbout Sean, Chief Accounting Officer
Parini Michael, Chief Legal Officer
Minor Lloyd, Director
HAWKINS WILLIAM A, Director
SHERWIN STEPHEN A, Director

How to read Form 4 transaction codes